Εγγραφείτε για να δημιουργήσετε ειδοποιήσεις για Οικονομικά Στοιχεία,
Οικονομικά Γεγονότα και περιεχόμενο από τους αρθρογράφους που ακολουθείτε
Δωρεάν Εγγραφή Έχετε ήδη λογαριασμό; Σύνδεση
Προσφορές
Όλοι οι τύποι
- Όλοι οι τύποι
- Δείκτες
- Μετ/κού Κεφαλαίου
- ETF
- Κεφάλαια
- Εμπορ/τα
- Νομίσματα
- Crypto
- Ομόλογα
- Πιστοποιητικά
Δοκιμάστε άλλη αναζήτηση
Ξεκλειδώστε premium δεδομένα: Ως και 50% μείον το InvestingPro ΕΞΑΡΓΎΡΩΣΗ ΕΚΠΤΩΣΗΣ
BNY Mellon Large Cap Securities Inc (DREVX)
Προσθήκη/Αφαίρεση από το χαρτοφυλάκιο
Προσθήκη στο Χαρτοφυλάκιο
19,44
-0,12
-0,61%
- Βαθμολογία Morningstar:
- Σύνολο Ενεργητικού: 2,42B
Dreyfus Fund Incorporated
19,44
-0,12
-0,61%
Επισκόπηση DREVX
Σε αυτή τη σελίδα θα βρεις ένα εις βάθος προφίλ για το BNY Mellon Large Cap Securities Inc. Μάθε μεταξύ άλλων για τα βασικά διοικητικά στελέχη, το σύνολο του ενεργητικού, τη στρατηγική για τις επενδύσεις και τα στοιχεία επικοινωνίας για το DREVX.
Πληροφορίες Συνδέσμου
Διεύθυνση
240 Greenwich Street
New York,NY 10286
United States
New York,NY 10286
United States
Τηλέφωνο
-
Διαδίκτυο
www.bnymellonim.com/us
Διοικητικά Στελέχη
| Όνομα | Τίτλος | Από | Μέχρι |
|---|---|---|---|
| Karen Miki Behr | - | 2021 | now |
| Βιογραφία | Miki is a member of Newton’s equity opportunities team. In her current role, she is a portfolio manager on the growth funds. Miki joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, Miki was a senior research analyst at Mellon Investments Corporation and The Boston Company Asset Management (both BNY Mellon group companies). Previously, she was a research analyst with a focus on healthcare. Over her 14 years at the firm, she covered the consumer staples, consumer discretionary and healthcare sectors across EM, EAFE and the US. Prior to joining BNY Mellon, Miki worked at Leerink Swann & Co., a healthcare investment bank, advising venture capital and private equity firms as well as pharmaceutical, biotech and medical-device companies on strategic growth opportunities. | ||
| Julianne D. McHugh | Portfolio Manager | 2021 | now |
| Βιογραφία | Julianne is a senior portfolio manager and Newton’s head of sustainable equities. As an experienced investor, she has been integral in identifying resources to support and enhance the integration of sustainability considerations into the firm’s investment practices. Julianne manages a selection of global and regional equity mandates. She is the lead portfolio manager for the BNY Mellon Large Cap Securities Fund, leveraging the global research team to deliver capital growth by investing in high quality US companies with strong positions in their industries. Julianne has led the Emerging Markets Research Fund since its inception in February 2014. She also serves as a portfolio manager for Newton’s Global Research Equity and Global First Decade Innovators strategies. Julianne joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, Julianne was a senior portfolio manager and senior research analyst at Mellon Investments Corporation and The Boston Company Asset Management (both BNY Mellon group companies). Prior to joining BNY Mellon, Julianne was an equity analyst at State Street Research & Management. Julianne has a BS in Finance from Lehigh University and an MBA with a Financial Management track from MIT Sloan School of Management. | ||
| Matt Jenkin | Senior Research Analyst | 2020 | 2023 |
| Βιογραφία | Matt is a senior research analyst on The Boston Company's Global Research team, covering the health care sector. He has 15 years of health-care investing experience and almost five years of health-care industry experience. Matt has served as a health care portfolio manager and analyst at Balyasny Asset Management, Lehman Brokers/Barclays Capital and Bluecrest Capital Management, where he managed global long/short equity health-care hedge funds and covered pharmaceuticals, biotechnology and health-care services. He also worked at Dreyfus from 2001 to 2005, where he incepted and managed the 4-star Morningstar-rated Dreyfus Health Care Fund and maintained health-care sector research coverage. Earlier in his career, Matt was a senior research scientist at SmithKline Beecham, where he helped to develop cardiovascular/general surgical techniques, designed surgical models for MRI in stroke research, and researched osteoporosis. Matt earned a bachelor’s degree in biology from Tulane University and an M.B.A. from New York University. | ||
| Erik Swords | - | 2019 | 2022 |
| Βιογραφία | Erik Swords with company 19 years, Industry experience 19 years Erik Swords is a head of global technology strategies on the fundamental thematic team at Voya Investment Management. He joined the firm following Voya’s integration of certain assets and teams comprising the substantial majority of Allianz Global Investors U.S. business, where he was a lead portfolio manager, managing director and led the U.S. global technology team. Prior to that, he worked at Newton Investment Management for 16 years, leading one of BNY Mellon’s largest technology strategies, along with several other thematic portfolios focused on technology and related sectors. Previously, he worked as a research analyst covering the software sector at Pilgrim Baxter Associates, Exis Capital Management and Credit Suisse First Boston Technology Group. Erik earned a BS in finance from Lehigh University. | ||
| Leigh N. Todd | Managing Director | 2015 | 2021 |
| Βιογραφία | Ms. Todd is a managing director and senior research analyst at Mellon Investments Corporation ("Mellon") and joined Mellon's predecessor company in 2005. She was previously employed by Dreyfus, and affiliated BNY Mellon company, since 2001. Prior to that, she was employed by State Street Global Advisors. | ||
| Robin Wehbe | Director | 2019 | 2020 |
| Βιογραφία | Robin Wehbe, CFA, CMT, is a director and equity research analyst at The Boston Company Asset Management, LLC (TBCAM), an affiliate of Dreyfus, where he has been employed since July 2006. He is a research analyst on TBCAM’s core research team, covering the energy, utilities and basic materials sectors. Prior to joining TBCAM, he was employed with State Street Global Advisors since 2003, most recently as a global research analyst, covering the basic materials sector. He also has been employed by Dreyfus since January 2009. | ||
| Barry K. Mills | Lead Portfolio Manager | 2010 | 2019 |
| Βιογραφία | Mills is a portfolio manager and senior managing analyst with Drefyus, his employer since 1999. Prior to joining the firm, he served as a portfolio manager with Phoenix Funds. From 1995-February 1997, he served as Director of Research for Howe and Rusling, Inc. | ||
| David M. Sealy | Portfolio Manager | 2010 | 2019 |
| Βιογραφία | Sealy is a portfolio manager at Dreyfus. He is a vice president, portfolio manager and research analyst at The Boston Company Asset Management, LLC, an affiliate of Dreyfus, where he has been employed since June 2005. He also has been employed by Dreyfus since May 1997. | ||
| Elizabeth Slover | Director/ Portfolio Manager | 2015 | 2019 |
| Βιογραφία | Elizabeth is the Director of The Boston Company’s Global Research Team, overseeing research for the U.S., EAFE and Emerging Markets. Elizabeth is also a Portfolio Manager on the US Large Cap Growth Equity strategy. Before joining The Boston Company, Elizabeth was with Chancellor LGT Asset Management (now Invesco), where she worked for the Director of Equities, responsible for managing the Equity Research Group. Before joining Chancellor, Elizabeth was in the Equity Research Department of Smith Barney, where she worked for the Chief Investment Strategist. She received a BA in Political Science from Union College. | ||
| Sean P. Fitzgibbon | - | 2005 | 2015 |
| Βιογραφία | Sean P. Fitzgibbon, CFA Executive Vice President, Senior Portfolio Manager Sean is the lead portfolio manager for the firm's Thematic Active Equity and Emerging Markets Equity strategies. Previously, he worked in research, covering Health Care, Consumer Discretionary, Consumer Staples, Financials and Utilities. Sean received a BS in economics from Northeastern University and an MBA from Babson College. He holds the CFA® designation and is a member of the CFA Institute and the CFA Society Boston. | ||
Γράψτε τις σκέψεις σας για τo BNY Mellon Large Cap Securities Inc
Σίγουρα θέλετε να διαγράψετε αυτό το διάγραμμα;
Διαγραφή Ακύρωση
Αντικατάσταση του επισυναπτόμενου διαγράμματος με νέο;
Αντικατάσταση Ακύρωση
Οδηγίες σχολιασμού
Επισύναψη Διαγράμματος στο Σχόλιο
Επιβεβαίωση μπλοκαρίσματος
Είστε σίγουροι πώς θέλετε να μπλοκάρετε τον/την %USER_NAME%;
Με αυτή την ενέργεια, εσείς και ο/η %USER_NAME% δεν θα μπορείτε να δείτε ο ένας τις αναρτήσεις του άλλου στο Investing.com.
Ο/Η %USER_NAME% προστέθηκε επιτυχώς στη λίστα μπλοκαρίσματός σας
Επειδή έχετε μόλις ξεμπλοκάρει αυτό το άτομο θα πρέπει να περιμένετε 48 ώρες πριν μπορέσετε να τον ξαναμπλοκάρετε.
Αναφορά προβλήματος
Πείτε μας τη γνώμη σας γι' αυτό το σχόλιο
Το σχόλιο σημειώθηκε
Σας Ευχαριστούμε!
Η αναφορά σας στάλθηκε στους επόπτες για επιθεώρηση